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RNAi screens have implicated hundreds of host pro-
teins as HIV-1 dependency factors (HDFs). While
informative, these early studies overlap poorly due
to false positives and false negatives. To ameliorate
these issues, we combined information from the ex-
isting HDF screens together with new screens per-
formed with multiple orthologous RNAi reagents
(MORR). In addition to being traditionally validated,
the MORR screens and the historical HDF screens
were quantitatively integrated by the adaptation of
an established analysis program, RIGER, for the col-
lective interpretation of each gene’s phenotypic sig-
nificance. False positives were addressed by the
removal of poorly expressed candidates through
gene expression filtering, as well as with GESS,
which identifies off-target effects. This workflow pro-
duced a quantitatively integrated network of genes
that modulate HIV-1 replication. We further investi-
gated the roles of GOLGI49, SEC13, and COG in
HIV-1 replication. Collectively, the MORR-RIGER
method minimized the caveats of RNAi screening
and improved our understanding of HIV-1–host cell
interactions.INTRODUCTION
Each infectious HIV-1 virion contains a collection of 12 distinct
viral proteins, including integrase (IN) and reverse transcriptase
(RT), as well as two copies of a 9 kb genome. Any viral require-752 Cell Reports 9, 752–766, October 23, 2014 ª2014 The Authorsments not self-fulfilled by these contents must be satisfied by
the infected host cell’s resources, a dynamic that has resulted
in significant morbidity and mortality. HIV-1 infection of a host
cell begins with the binding of the virus’ envelope spike (ENV)
to the coreceptors CD4 and either CXCR4 or CCR5 (Goff,
2007). Once engaged, ENV fuses the viral and host membranes
to create a pore through which the viral contents enter the cell.
Upon entry, the virus uses the host’s dinucleotide triphosphates
to reverse transcribe its RNA genome into DNA, forming a prein-
tegration complex (PIC). The PIC courses along microtubules
toward the nucleus, which it enters via the nuclear pore complex
(NPC). Emerging amidst the chromatin, the PIC interacts with
LEDGF/p75, leading to HIV-1’s preferential integration into an
actively transcribed gene (Ciuffi et al., 2005). The integrated pro-
virus next exploits the host’s transcriptional machinery to pro-
duce viral mRNAs, the most crucial being Tat, which together
with the host complex, PTEF-b, ensures transcriptional elonga-
tion along the provirus. Once synthesized, the soluble viral com-
ponents are packaged within a core of structural proteins: p24
capsid (CA), matrix, p7, and p6. ENV is translated on the endo-
plasmic reticulum (ER), modified in the Golgi, and trafficked to
the surface to ultimately coat the viral envelope. Viral budding
and abscission relies on the ESCRT proteins, which execute
roles similar to those played during cytokinesis (Sundquist and
Krausslich, 2012).
Elucidating host-viral interactions has been a longstanding
pursuit of the scientific community, with the goal of using such
knowledge to both treat and cure disease. Yet, although we
know that HIV exploits multiple proteins, there remain many viral
life-cycle processes that are at best partially defined. We and
others have performed genetic screens to identify HIV-1 depen-
dency factors (HDFs) and uncovered many host genes involved
in HIV infection (Brass et al., 2008; Ko¨nig et al., 2008; Zhou et al.,
2008). However, while this work has produced successes, it has
also been hampered by low concordance across the screens
due to false negatives, false positives, and a gradation of
small interfering RNA (siRNA) efficacies resulting in variable
hypomorphism.
With the goal of approaching a systems-level understanding of
HIV-host factor interactions and to improve upon the initial HDF
screens and address the lack of overlap between siRNA screens
in general, we expanded our earlier efforts by using multiple
orthologous RNAi reagents (MORR) coupled with integrative
analysis tools. Our rationale in pursuing this strategy was
2-fold: first to take advantage of the strengths of several inde-
pendent RNAi design approaches, and second to analyze the
data sets using RNAi-focused informatics tools and screen-spe-
cific gene expression data. We analyzed the MORR screens by
selecting candidates using a cutoff coupled with a reagent
redundancy validation round. In addition, the screens were
also assessed by quantitatively integrating all of the primary
data sets using an established bioinformatics program to pro-
vide a global statistical evaluation of each gene’s role in HIV-1
replication. This comprehensive effort is validated by the discov-
ery of known factors and the identification of multiple novel
HDFs, demonstrating that using MORR can improve our under-
standing of HIV-1-host cell interactions.
RESULTS
MORR Screens Find Host Factors that Modulate HIV-1
Replication
One source of variability in the historical HDF screens is their
being performed by different groups with distinct reagents. To
control for this, we investigated HIV-1-host cell interactions by
employingMORRwith an established image-based assaywhere
HeLa cells expressing CD4 and CXCR4 are transfected with
siRNAs, then exposed to infectious HIV-1 (HIV-IIIB; Brass
et al., 2008). Postinfection, the cells are immunostained for CA
in conjunction with DNA staining to determine cell number.
Due to several points, including infectivity, we used a different
HeLa cell line, P4-P5 MAGI cells (MAGI), instead of the TZM-bl
HeLa cell line used in the SMARTpool screen.
We screened three libraries: Silencer Select (21,584 pools,
Ambion), esiRNA (15,300 pools, Sigma), and the SMARTpool
RefSeq27 Reversion Human 5 (SMART-Rev, 4,506 pools, Dhar-
macon; Figure 1A; Table S1). The last library is a collection of
replacement siRNAs produced because of RefSeq revisions.
These libraries employ unique design strategies and/or target
additional genes (SMART-Rev), making them complementary
to one other and the earlier libraries. The esiRNAs are mixtures
of overlapping siRNAs (18–25 bps) made by endoribonuclease
digestion of longer RNAs (Kittler et al., 2007). Thus, less concen-
tration-dependent off-target effects (OTEs) are expected versus
conventional pools. Silencer Select siRNAs incorporate locked
nucleic acids (LNAs) to increase the strength and specificity of
binding to mRNA (Puri et al., 2008). An assumption with the
MORR approach is that each of the libraries uses unique siRNA
sequences for a given gene; this is likely because the libraries
were designed with distinct algorithms. A random survey of
1017 Silencer Select and 1,356 matched SMARTpool siRNAs
targeting the same 339 genes found <5% overlap (Table S1).CAnalysis of the MORR Screens
The MORR screens were analyzed using a traditional reagent
redundancy method as well as by quantitatively integrating all
of the primary data sets. The latter approach considers the
magnitude of the effects of all the independent RNAi reagents
tested in order to address issues of partial penetrance for each
gene. Each method has it strengths, as we discuss below. In
the traditional method, genes were chosen for evaluation if the
percentage of HIV-1 infected cells was %50% or R200% of
the plate mean and cell number was R50% of the plate mean.
Next, in the validation round, the siRNA pool components were
tested individually (Table S1). For the esiRNA pools, we retested
the candidates from the primary screen. In the validation data
sets, genes with two or more siRNAs that confirmed were
deemed high confidence based on the reagent redundancy prin-
ciple (Echeverri et al., 2006).
TheMORRscreens identified several pathways andmacromo-
lecular complexes whose components were shared across the
three high-confidencedata sets (i.e., NPC; Figures 1B–1E; Tables
S1 and S2) as well as the high-confidence data sets from the
earlier screens that used three distinct libraries: one constructed
by QIAGEN for the Genomics Institute of the Novartis Research
Foundation (QIAGEN, Ko¨nig et al., 2008), one designed by Ro-
setta InPharmatics and synthesized by QIAGEN for Merck &
Company (Rosetta, Zhou et al., 2008), and the commercially
available Dharmacon siRNA library (SMARTpool; Brass et al.,
2008). The QIAGEN library targets each of 20,000 genes with
up to three pools containing two oligos per pool. The Rosetta
library targets 19,709 genes with 22,329 pools of three siRNAs
per gene. The SMARTpool library targets 21,121 genes using
pools of four siRNAs per gene. For the NPC, the strongest de-
pendency was seen with the spoke ring and scaffold ring genes
(Figures 1B and 1C; Table S2). Among the scaffold ring proteins,
only NUP37 failed to score in one or more screens. Among the
mediator (MED) components recovered across the screens, we
detected a stronger viral reliance on proteins located in the
head and middle portions as compared to the tail (Figures 1D
and 1E; Table S2), suggesting that the tail plays a smaller role
in long terminal repeat (LTR) activation.
The earlier screens identified three HDFs (RELA, MED6, and
MED7) in all three screens and 34 in two or more screens (Fig-
ure S1A; Table S2). The MORR screens recovered 13 of these
original 34 common HDFs and expanded the list of HDFs in
two or more screens to 114, out of a total of 1,117 selected
across all six screens (Figures S1B and S1C). Because RNAi
produces variable hypomorphism, we assessed how the 114
HDFs scored in the Silencer Select screen and found their
mean percent infection value was less than the screen as a
whole (Figure S1D); this suggested that the phenotypic signifi-
cance of genes whose depletion resulted in partial penetrance
might be better appreciated by quantitatively integrating the
screens’ data.
Low Overlap and High False-Positive Rates among All
HDF Screens
A comparison of the high-confidence lists from the MORR
screens and the three previous screens (Table S2) demonstrated
a low percentage of exact gene overlap (Silencer Select 19.9%;ell Reports 9, 752–766, October 23, 2014 ª2014 The Authors 753
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Figure 1. MORR Screens Identify Host Factors that Modulate HIV-1 Replication
(A) The results of the screens with the siRNA pools ranked in order of their normalized percent infection (log2 scale).
(B) NPC genes required for HIV-1 replication. Schematic of the NPC (left), with scaffold ring (red), spoke ring (yellow), central channel (green), nuclear basket
(purple), and cytosolic filaments (blue) components. Detail of the NPC’s spoke ring (far left) demonstrating the high percentage (90%) of components, including
SEC13 (orange), that scored in one ormore of the HDF screens (red lettered). The estimated diameter of the NPC lumen is provided. For reference the HIV-1 PIC is
28 nm across (Miller et al., 1997).
(C) NPC genes that met selection criteria in one or more of the HDF screens are grouped and color-coded by their respective component in the table at right, with
gray denoting a gene that did not score in any of the screens.
(D) MED genes required for HIV-1 replication. Schematic of MED (left), with the head (blue), middle (green), and tail (yellow) components shown as well as the
complex’s association with RNA polymerase II (RNAPII, red).
(E) MED genes that met selection criteria in any of the screens are highlighted in their respective component colors in the table at right, with gray signifying a gene
that did not meet selection criteria in any screen.SMARTpool 19.2%; SMART-Rev 14.0%; esiRNA 12.7%;
Rosetta 10.7%; QIAGEN 10.2%). This likely arises from a combi-
nation of OTEs, false negatives, variable hypomorphism, and
differences between methods; these assumptions are consis-
tent with previous comparisons revealing that while similar path-754 Cell Reports 9, 752–766, October 23, 2014 ª2014 The Authorsways and complexes are likely to be detected across screens,
the overlap of exact genes is much less (Hao et al., 2013; Meier
et al., 2014). Comparing the primary data sets of the HDF
screens for bothMED andNPC revealed that themajority of sub-
units for each complex passed selection criteria (Figures 1B–1E
and S2A–S2B; Table S2). For the QIAGEN library primary screen
data set (Ko¨nig et al., 2008), we selected genes as HDFs if two or
more of the pools decreased infection to <55%. Cell viability
data were not available for this data set. For the Rosetta (Zhou
et al., 2008) and SMARTpool (Brass et al., 2008) primary screen
data sets screens, we selected pools that decreased infection to
<50% without decreasing cell number to <40% of the negative
control. Using these criteria, the screen data sets detected
92.3% of MED and 72.4% of NPC components, attesting to
the comprehensiveness (saturation) of the collective HDF
screens (Figure S2; Table S2). Interestingly, while some of the
subunits scored in multiple screens, others scored in just one
or two. While these results highlight the variable hypomorphism
inherent in RNAi screening, they also demonstrate that the
screens in aggregate are approaching saturation for these
complexes.
The Silencer Select and SMART-Rev screens identified 33
previously unrecognized high-confidence HDFs that were vali-
dated with two or more individual siRNAs (Tables S1 and S2).
Of note, siRNAs against TNPO3 were not in the esiRNA library;
however, a TNPO3 esiRNA inhibited HIV-I (Figure S2C). Although
we did find several common pathways and clusters across the
MORR screens, the exact gene overlap was again low (12%–
20%; Table S2); however, it was at least 2-fold higher than the
largest seen earlier (SMARTpool and Rosetta, 18 genes or
6.4%). In contrast to the earlier screens, this occurred with the
MORR screens being performed identically. We conclude that
along with OTEs and screen design, varying siRNA efficacies
result in false negatives and contribute to the low exact gene
overlap between similar screens.
Quantitative Integration of the HDF Screens Using
RIGER
The Silencer Select screen’s mean percent infected cell value
was greater than that of the 114 common HDFs even though
only 54 of these genes met selection criteria, revealing that
some siRNAs were partially inhibiting HIV-1 (Figure S1D). This
suggested that one contribution to the lack of overlap is a grada-
tion of hypomorphism produced by distinct siRNA reagents
combined with absolute cutoffs in hit selection. We also used a
second analysis method that produces an aggregate phenotypic
significance score derived by quantitatively integrating multiple
primary data sets. To this end, we sought an RNAi-focused
method that calculates the cumulative significance ofmultiple in-
dependent RNAi reagents all targeting the same gene. Among
several, we chose the RNAi gene enrichment ranking (RIGER)
method, which uses a weighted likelihood ratio to calculate a
gene-specific enrichment score based on the rank distribution
of each individual RNAi reagent among all those screened (Luo
et al., 2008). This enrichment score is represented by a p value
that denotes the likelihood that the gene plays a role in the
phenotype of interest. Although RIGER was originally designed
to analyze similar screens using different cell lines and the
same pooled RNAi library, we reasoned that it could also be
used to evaluate the HDF screens that assess the same pheno-
type but use different RNAi libraries. Because the three screens
(Silencer Select, esiRNA, and SMARTpool) performed by our
group were most alike, we used RIGER to analyze these firstC(RIGER3; Table S3). To simplify this analysis, we replaced the re-
sults of the corresponding siRNAs in the original SMARTpool
data set with the revised SMART-Rev screen values. We found
that of the three RIGER integrative approaches, the second
best (SB), weighted sum (WS), or Kolmogorov-Smirnov (KS),
either the SB or WS method performed optimally (see below).
A comparison of the highest ranking 355 RIGER3 HDFs to the
top candidates from 2 of the earlier HDF screens performed by
Ko¨nig et al. (QIAGEN; Ko¨nig et al., 2008) and Zhou et al. (Rosetta;
Zhou et al., 2008) revealed a significant overlap in exact genes
detected, with 321% more exact genes than expected seen for
Konig et al. (22 genes, p value = 1.5 3 108, Fisher exact test)
and 309% more for Zhou et al. (27 genes, p value = 6.4 3
1010). Next, the analysis was extended to all five screens
(RIGER5; Table S3; Zhou et al., 2008; Ko¨nig et al., 2008; Brass
et al., 2008). For RIGER5, we employed all three approaches
(SB, WS, and KS) and used the Liptak method to derive a com-
bined p value and q-value (false discovery rate [FDR]; Liptak,
1958). Both the RIGER3 and RIGER5 analyses highly ranked
multiple known HDFs: TNPO3 and MED28 (Table S3). Gene
enrichment analyses of the top-ranked 528 genes from RIGER5
HDF (q-value < 0.2) was performed usingConsensusPathDB-hu-
man (http://cpdb.molgen.mpg.de) in conjunction with the REAC-
TOME, CORUM, and KEGG databases (Figure 2A; Table S3).
Consistent with RIGER identifying relevant factors, these ana-
lyses demonstrated the significant enrichment of known HDF
pathways and complexes, including the spliceosome, RNA poly-
merase-associated factors, MED, NPC, and components of the
Rev-associated mRNA export pathway. Gene enrichment anal-
ysis of the RIGER3HDFs (top 500 genes, score < 0.127, p value <
0.03; Table S3) was similar. For theHRFs, we performed aRIGER
analysis using the MORR screen data sets and the SB method
(Table S3). Gene enrichment analysis was also performed using
the top 260 RIGER3 HRFs (RIGER score < 0.1057, p value <
0.02; Table S3). Interestingly, this showed that both subunits of
the facilitates-chromatin-transcription (FACT) complex,
SUPT16H and SSRP1, ranked highly.
The MORR-RIGER Method Enhances Enrichment
The RIGER3 and RIGER5 HDF data sets were compared by
determining their respective levels of enrichment for each of
four expert-selected gene sets (HIV infection, NPC, spliceo-
some, MED; http://www.reactome.org; Figure 2B; Table S3).
Enrichment was calculated by determining the area under a
curve (AUC) generated by plotting the percent fraction of
expert-selected genes encountered moving from high to low
on the ranking lists. A completely random set of genes would
generate a line represented by Y = X and have an AUC of 50.
The three RIGER methods performed similarly across the test
sets, with the best overall AUCs seen with RIGER5 SB. For three
of four gene sets, the KS method was significantly improved by
including all five screens as compared to the analysis of only
three screens. The greatest advantage of integrating all five
screens was seen with the MED gene set. The analyses using
the SB andWSmethods did not show any significant differences
between RIGER3 and RIGER5. Interestingly, the RIGER5 SB
analysis showed an AUC advantage over the individual MORR
screens (SMARTpool, Silencer Select, and esiRNA) using eitherell Reports 9, 752–766, October 23, 2014 ª2014 The Authors 755
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Figure 2. MORR Screen Gene Enrichment Analyses and Gene Expression Filtering
(A) Gene enrichment analyses of the RIGER5 HDFs. Highly enriched KEGG, REACTOME, and CORUM complexes and pathways among the top 550 RIGER5
HDFs are shown (Table S3). Overlying fractions to the right of each pathway’s or complex’s name indicate the number of HDFs identified in the analysis over the
total number of genes in the set. The red line indicates alog (p value) of 1.3 (p value of 0.05). Specific complex and pathways are abbreviated, with a key to their
full names provided in Supplemental Experimental Procedures.
(B) RIGER analyses comparisons. The RIGER3 and RIGER5 HDF data sets produced using one of three methods (WS, SB, or KS) were compared by assessing
their respective levels of enrichment for each of four expert-selected HDF gene sets (HIV infection, NPC, spliceosome, MED; http://www.reactome.org). An
enrichment estimate for each derivation was calculated by determining the area under a curve (AUC) generated by plotting the percent fraction (fraction) of
expert-selected genes encountered moving from the lowest to highest p value on the ranked gene lists (rank position).
(C) Microarray analysis was used to determine the levels of gene expression in the HeLa MAGI cells used in the MORR screens. The complete data set is arrayed
with the red symbols representing the top 85 RIGER5 HDFs shown in the HDF cell model (Figure 3A). Specific HDFs and HRF/HCFs are noted (yellow). Two likely
OTEs, the olfactory receptors (OR2AT4 and OR2AJ1), are shown in purple. The blue line represents the intron probe median. The green line represents the
antisense probe mean. MED27, whose expression level falls below that of the intron probe median, is shown.
(D) OTE analysis using genome-wide enrichment of seed sequence matches (GESS). All siRNAs (313) that scored in the validation round for the Silencer Select
library screen were analyzed. The significant enrichment of RefSeq CDSs that have a 7-mer seedmatch to these 313 siRNAs was determined by comparison to a
set of inactive validation round siRNAs. Several potential OTEs are highlighted (green squares). A similar analysis was performed to look for on-viral effects (OVEs)
using the HIV-1 genome sequence (Figure S2D).the NPC or MED test sets, with this being most notable in the
initial part of the curve that covered genes whose loss decreased
HIV infection by >50% (Figure S3A). The RIGER method also
demonstrated an AUC advantage over the individual MORR
screens in highly ranking the 34 (three original screens) and
114 (all six screens) commonHDFs (Figure S3B; Table S3). Over-
all, the increased enrichment among these sets suggests that the
use of the MORR-RIGER method to quantitatively integrate the
screen data sets produces a less biased and more robust HDF
network.756 Cell Reports 9, 752–766, October 23, 2014 ª2014 The AuthorsUsing Gene Expression Filtering to Decrease OTEs
The highest AUCs were seen for the NPC and the lowest in the
HIV infection set; this may arise because several genes in the
latter set (i.e., HLA; Table S3) are not expressed in the screening
cells. Microarray analysis (Affymetrix GeneChip human 2.0 ST
array) was used to determine the levels of gene expression in
the MAGI cells. The values for the probe set in the microarray
were matched to the genes present in the siRNA libraries based
on searching several identifiers. Overall, we matched 17,205
(81.5%) and 18,168 (83.6%) genes with expression data in the
SMARTpool and Silencer Select screens, respectively (Tables
S1 and S4). The median of the negative control intron probe
set was used as a cutoff for gene expression, producing a list
of 12,115 common genes in the siRNA libraries that are likely
to be expressed in the MAGI cells as well as the other HeLa
cell line used by Zhou et al. (Rosetta; Zhou et al., 2008). We
used this expression data as a filter (gene expression filtering)
to remove RIGER5 HDFs whose mRNAs were present at levels
less than the intron probe median because they most likely rep-
resented OTEs. Using this approach we found that among the
top 150 RIGER5 SB genes only 26 fell below the intronistic me-
dian (17.3%), including two olfactory receptor genes (Figure 2C).
There was no correlation between gene expression and RIGER
ranking (Figure S4). However, while this approach is helpful, it
identified MED27 as an OTE, which is unlikely. Therefore, with
certain exceptions, we envision gene expression filtering to be
useful for decreasing OTEs.
High False Negatives Impact Screen Comparisons
Comparison of the screens highlighted that while either distinct
screens or those done by the same group using different siRNA
libraries may detect functionally related genes, they are much
less effective in detecting the same gene (Bushman et al.,
2009). As we and others have noted, false negatives as well as
false positives occur frequently in RNAi screening (Adamson
et al., 2012; Hao et al., 2013). Earlier comparisons have had to
qualify these observations due to potential variation in experi-
mental design and reagents; however, in this instance, we
have controlled for these variables between the esiRNA and
Silencer Select screens and still find a low degree of overlap
within two known HDF complexes, MED and NPC (Figures 1,
2, S1, and S2; Table S2). Extending this comparison made
apparent that the degree of false negatives is both library and
screen dependent (Table S2). For example, the Rosetta library
performed well in the primary screen when identifying MED
(8.3% estimated false-negative rate for MED), even though sec-
ondary screens removed these candidates from the published
high-confidence list, considerably lowering the overlap between
this and the other two early HDF screens. Similarly, with the NPC
genes, the Rosetta screen was the most effective; however, in
this instance, toxicity was a major factor in diminishing overlap,
suggesting that the creation of hypomorphs with less penetrant
phenotypes was optimal. Based on the average value seen with
MED and NPC, the screens displayed 35.7%–66% false-nega-
tive rates (Rosetta 35.7%, Silencer Select 59.0%, QIAGEN
65.9%, SMARTpool 63.3%, and esiRNA 66.0%; Table S2).
RIGER ranks genes based partly on their similarly scoring
across multiple screens and in some cases is improved by the
integration of additional screen data sets. For example, genes
that decreased infection across most of the screens (MED6
and MED8) had lower p values in RIGER5 versus RIGER3. In
contrast, COG2-4, which scored only in the MORR screens, dis-
played larger p values in RIGER5 than in RIGER3. This is also
seen with the greater number of MED and NPC subunits
identified as HDFs using a simple cataloging of those that met
selection criteria in any of the siRNA screens (ALL5) versus those
that were ranked in the top 550 in RIGER5 (RIGER5; Figures S2A
and S2B).CUse of GESS to Rule Out Prominent OTEs
Genome-wide enrichment of seed sequence matches (GESS)
identifies OTEs (Sigoillot et al., 2012). OTEs result primarily
from the binding of siRNA seed sequences to cognate mRNAs
that they were not designed to deplete. GESS detects OTEs by
searching for matches between the collective RefSeq mRNAs
(coding sequences [CDSs], 50 and 30 UTRs) and the seed se-
quences of the individual siRNAs that elicit the phenotype of in-
terest in the validation round (active siRNAs). The siRNAs that
do not score in the validation round (inactive siRNAs), or a
scrambled set of the active siRNA sequences, serve as negative
controls. An mRNA that pairs more frequently with the validation
round seed sequences compared to the scrambled or inactive
sequences suggests an OTE. Using GESS, we found that
several genes were recognized by the Silencer Select validation
round seed sequences more frequently than the scrambled se-
quences (Figure 2D; Table S5). However, these results did not
pass a statistical significance test (Fisher’s exact test with Ben-
jamini-Hochberg correction, alpha = 0.05). None of the putative
OTE target genes represent a known or putative HDF. Based on
the GESS analysis, we estimate that <10% of the validation
round siRNAs that confirmed in the Silencer Select screen are
OTEs.
We usedGESS to look for siRNAs that inhibit HIV-1 by promis-
cuously binding to viral mRNAs (on-viral effects [OVEs]) using the
HIV-1 genome and detected no significant events (Figure S2D).
Therefore, the Silencer Select screen was not dominated by
one or more prominent OTEs, as with certain screens (Sigoillot
et al., 2012). The likely OTEs identified by gene expression
filtering but that were not noted by GESS as OTEs suggest
that there are more complex interactions occurring, possibly
involving less potent OTEs.
We next combined the RIGER5 analysis and gene expression
filtering to generate a top 150 HDF list (Table S6). Using this list,
we constructed an updated hypothetical model cell representing
key steps in the HIV-1 life cycle as well as where 86 of the
RIGER5 HDFs might function based on the literature (Figure 3A;
Table S6; Brass et al., 2008). Inclusion criteria were the HDF pos-
sessing a gene expression value greater than the intron control
as well as literature reporting a function. Genes in the RIGER
top 150 that did not meet these criteria are not pictured (Table
S6). We have also created a table containing RIGER rankings
and the normalized primary screen data from all of the screens
for these RIGER top 85, as well as the common 34 HDFs and
the HDFs that were further evaluated below (Table S7). Given
the near saturation of multiple major complexes in the RIGER5
data set, as well as their overlap with the events of the HIV-1
life cycle, this model likely approximates themajority of the virus’
requirements in HeLa cells.
Network Analysis of HDFs and HIV-Human Protein
Complexes
A proteomics study identified >430 host factors that interact
with HIV-1 proteins using a quantitative ranking system (MiST;
Jager et al., 2012). To find connections between this resource
and HDFs, we performed a network analysis of the RIGER3
(p values < 0.05; Table S3) and proteomics data sets (MiST
score > 0.75) using a heuristic approach starting with a centralell Reports 9, 752–766, October 23, 2014 ª2014 The Authors 757
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Gene Expression Filtering/OTE
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Top Candidate Evaluation 
Figure 3. MORR Screen HDF Model and HIV-Host Proteome Analyses
(A) Using the RIGER5 list as a starting point, we constructed an updated hypothetical model cell depicting key steps in the HIV-1 life cycle as well as where 85 of
the HDFs might function based on the literature (Table S6).
(B) Network showing connections between HDFs (top-ranked 123 from RIGER3 SB analysis) and host proteins that interacted with HIV viral components (Ja¨ger
et al., 2012). Human protein reference database (HPRD).
(C) MORR screening is followed by RIGER analysis and traditional reagent redundancy validation. Gene expression filtering and the GESS program are next used
to remove likely OTEs. Based on these results, candidates are selected for further evaluation.scaffold of first-order (direct) HDF-HDF interactions. We next
extended this to direct interactions between a HDF and a host
factor that interacted with HIV [viral component (Figure 3B),
first-order (direct interactions with enrichment p % 0.002)].
This analysis identified several HDFs that directly interact with
an HIV protein (HDF: viral protein, ATAD3A: Vpu, RANBP2:
Vpu, PSMB6:gp160, THRAP3: Gag, RUVBL1: POL, CCNT1:
Tat, DNAJB2: Vif, SEC61A1: ENV). Among these HDF-HIV inter-
actors was RUVBL1, a NuA4 histone acetyltransferase complex
member that modulates transcriptional activity via histone modi-
fication (Jha et al., 2008). In line with this broad-acting role,
RUVBL1’s depletion with either of three siRNAs inhibited the
replication of all the retroviruses tested, including MLV-GFP
and pPHAGE-GFP, the latter being dependent on a cytomegalo-
virus (CMV) cis element for expression (Figures S5A–S5C).
To this point, we have outlined a workflow for RNAi screening
starting with MORR screens followed by a reagent-redundancy-
based validation round and quantitative integration of screen
data sets using RIGER. We have also used the GESS program
and gene expression filtering in an attempt to decrease OTEs758 Cell Reports 9, 752–766, October 23, 2014 ª2014 The Authors(Figure 3C). In this next section, we further evaluate several
top-candidate HDFs identified above.
HIV-1 Requires Specific Host Cell Nucleotide Synthesis
Enzymes
The MORR screens detected multiple factors involved in
nucleotide metabolism. While wholly expected that HIV-1 re-
quires such pathways, these results nonetheless identify specific
enzymes as HDFs. For example, the MORR screens identified
HDFs involved in pyrimidine (UMPS) and purine metabolism
(ATIC; ADSS; Cheong et al., 2004), as well as both subunits
(RRM1 and RRM2) of a holoenzyme necessary for the formation
of deoxyribonucleotides from ribonucleotides (RNR; Figure 4A).
To validate the role of ATIC in viral replication, we transfected
cells with siRNAs against ATIC or a control nontargeting siRNA
(Con). After 72 hr, the transfected cells were challenged with
HIV-IIIB for 48 hr and the percent infection determined. In paral-
lel, we also assessed siRNA-mediated depletion (Figures 4B and
4C). All the siRNAs depleted ATIC and inhibited HIV-1, consis-
tent with ATIC being an HDF.
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Figure 4. HIV-1 Requires Specific Nucleotide Synthesis Enzymes and the THOC/TREX Complex
(A) Multiple nucleotide synthesis enzymes (ATIC, UMPS, and RRM) were detected in the screens and RIGER analyses (%5% RIGER = lowest 5% q-values).
(B) MAGI HeLa cells were transfected with either nontargeting control siRNA (Con) or siRNAs targeting ATIC (1–4). At 72 hr posttransfection, cells were infected
with HIV-1 IIIB. After 48 hr, cells were immunostained with an anti-HIV-1 p24 CA antibody (anti-CA). The percentage of infected cells was measured using image
analysis software and normalized to the control siRNA transfected cells.
(C) Whole-cell lysates from the indicated cells in (B) were subjected to immunoblotting using the noted antibodies. kDa, kilodaltons; GAPDH, loading control.
(D) Schematic model of the human THO/TREX complexes (Viphakone et al., 2012). Subunits detected in theMORR screens and RIGER5 SB analysis are shown in
red (%5% RIGER = lowest 5% q-values).
(E) HeLa cells were transfected with the indicated siRNAs and assessed as in (B).
(F) siRNA-mediated depletion of THOC2 was evaluated by quantitative PCR (qPCR) measurement of mRNA levels from the cells in (E). mRNA levels were
normalized to those of the control siRNA transfected cells.
Results throughout are the mean of three independent experiments ± SD. *p% 0.05 (Student’s t test).THOC2, the COG Complex, and SUPT16H Play Roles in
HIV-1 Replication
The THO/TREX complex couples transcription to the export of
poly(A) RNA and mRNAs derived from intronless genes
(Stra¨sser et al., 2002). Multiple THO/TREX components were
highly ranked by RIGER5, including THOC1/Hpr1 (p value <
0.05), THOC2 (p value < 0.001), and THOC3/Tex1 (p value <
0.05; Figure 4D). Three independent siRNAs targeting THOC2
validated for both their targeting efficacy and their effects on
HIV-1 infection (Figures 4E and 4F). Additional subunitsC(THOC4, THOC5, and THOC7) were ranked lower by
RIGER, perhaps due to the existence of different com-
plexes with varying significance for HIV-1 replication. In
support of this idea, and in accordance with an existing model
(Figure 4D; Viphakone et al., 2012), THOC1/Hpr1, THOC3/
Tex1, and THOC6 may directly associate with THOC2, sug-
gesting these proteins may form a subcomplex that is impor-
tant for viral replication or that silencing any one of them may
decrease the stability of the others, thereby enhancing
penetrance.ell Reports 9, 752–766, October 23, 2014 ª2014 The Authors 759
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Figure 5. COG Plays a Role in HIV-1 Replication
(A) Schematic of the COG complex. Subunits of COG lobe A (COG-LA) detected in the MORR HDF screens and RIGER5 analysis (%5% RIGER = lowest 5%
q-values) are shown in red. Genes in blue represent those with q values in the highest 95%.
(B) HeLa cells were transfected with the indicated siRNAs. At 72 hr after transfection, cells were infectedwith HIV-1 IIIB. After 48 hr, cells were immunostainedwith
anti-CA. The percentage of infected cells was normalized to the control siRNA-treated cells.
(C) siRNA-mediated depletion was evaluated by qPCR measurement of the endogenous mRNA levels from (B). mRNA levels were normalized to those of the
control siRNA-transfected cells.
(D) HeLa cells were transfected with either nontargeting control siRNA or the indicated siRNAs. At 72 hr posttransfection, cells were infected with one of the
following VSV-G-pseudotyped viruses: HIV-YFP, MLV-GFP, LTR-GFP, or pPHAGE-CMV-ZSG. After incubation for 48 hr, the percentage of positive cells was
determined and normalized to controls.
Results throughout are the mean of three independent experiments ± SD. *p% 0.05 (Student’s t test).COG functions in retrograde vesicular transport within the
Golgi and is critical for the recycling of glycosyltransferases
(Miller and Ungar, 2012). In mammalian cells, COG consists of
eight subunits (COG1–8) arranged into two lobes: lobe A
(COG-LA, COG1–4) and lobe B (COG-LB, COG5–8). Our earlier
screen had identified COG-LA as being required for HIV-1 repli-
cation along with the COG-interacting proteins STX5 and
SCFD1, and this was seen again in both the Silencer Select760 Cell Reports 9, 752–766, October 23, 2014 ª2014 The Authorsand esiRNA screens, with RIGER3 highly ranking COG-LA along
with STX5 and SCFD1 (Figure 5A; Table S3). Coupled RNAi and
phenotype assays showed that multiple siRNAs targeting each
of the COG-LA subunits, or STX5 and SCFD1, decreased viral
replication and the mRNA levels of their respective targets (Fig-
ures 5B and 5C). We next used several vesicular stomatitis virus-
G (VSV-G) pseudotyped viruses to investigate the role of these
factors in replication: The HIV-yellow fluorescence protein
(HIV-YFP), HIV-1 LTR-green fluorescence protein (LTR-GFP),
and CMV Zoanthus species green (CMV-ZSG) viruses were
used to evaluate involvement in ENV-mediated entry and/or
Tat-dependent LTR transactivation, while the gamma retrovirus,
Moloney leukemia virus-GFP (MLV-GFP) virus, was used to test
for lentiviral specificity. The depletion of any three COG-LA
members or SCFD1 reduced infection by all of these viruses (Fig-
ure 5D). These results indicate that COG-LA and SCDF1 modu-
late the infection of viruses expressing either VSV-G or HIV-1
ENV potentially via their regulation of glycosylation.
SUPT16H and SSRP1 comprise the FACT complex, which
regulates nucleosome formation and transcription elongation
(Belotserkovskaya et al., 2003). Multiple siRNAs were confirmed
in the validation round for SUPT16H as increasing viral infection,
with the greatest impact seen with the transfer of viral superna-
tant (part two, Figures S6A and S6B). These data are consistent
with experiments in yeast showing that FACT regulates the basal
transcription of the 50 HIV-LTR. Loss of SUPT16H helps alleviate
repression of the cryptic promoters of latent HIV proviruses (Gal-
lastegui et al., 2011). To test the significance of these events in a
more physiologic setting, we stably transduced primary human
CD4+ T cells with three independent small hairpin RNAs
(shRNAs) against SUPT16H. When these cells were infected
with HIV-1 IIIB, the depletion of SUPT16H produced a 3-fold
increase in Gag mRNA levels (Figures S6C and S6D). Similar re-
sults were obtained with VSV-G-pseudotyped HIV-1 NL4-3-
GFP, but not with MLV-GFP (Figure S6E). We next evaluated
SUPT16H’s effect on the LTR promoter in HeLa cells. Using
the lentiviral vectors described above, we demonstrated that
SUPT16H levels modulated the activity of the HIV LTR, but not
the CMV promoter (Figure S6F). We also used an LTR-driven
luciferase reporter assay to show that the expression of HIV-1
Tat and the depletion of SUPT16H led to further enhanced re-
porter activity and that this required the presence of the TAR
sequence, which recruits Tat to the LTR, consistent with previ-
ous work suggesting that SUPT16H is a HIV-1 competitive factor
(HCF; Figure S6G).
GOLGI49 Is Required for HIV-1 Entry
C3orf58 is a Golgi protein of unknown function that was a top
candidate in the MORR screens (Takatalo et al., 2008). Based
on this and the data below, we have named this gene GOLGI49.
In validation experiments, the transfection of any of seven
GOLGI49 siRNAs depleted mRNA levels and reduced the repli-
cation of both HIV-1 IIIB (X4-tropic) and BaL (R5-tropic) viruses
(Figures 6A, 6B, and S7A). We then performed a rescue experi-
ment by restoring HIV-I replication with a stably expressed
GOLGI49 cDNA in conjunction with an shRNA targeting the
endogenous mRNA’s 30 UTR (Figures 6C and 6D). Expression
of three distinct shRNAs in primary human CD4+ T cells reduced
the infection of HIV-1 NL4-3-GFP, and these events correlated
with efficient mRNA depletion (Figures 6E and 6F). In both
gain- and loss-of-function experiments, we determined that
GOLGI49 was specifically required for replication of HIV-1 IIIB,
but not two VSV-G-pseudotyped HIV-1 viruses, leading us to
postulate that GOLGI49 may be required during the ENV-depen-
dent phase of infection (Figures 6G and 6H). Consistent with this
notion, GOLGI49 depletion decreased late RT levels (Figure 6I).CA b-lactamase-Vpr (BlaM-Vpr) fusion assay revealed that
GOLGI49 depletion reduced the fusion of pseudotyped viruses
expressing the ENV of HIV-IIIB (HX2B), but not viruses express-
ing VSV-G (Figure 6J). Surface expression of neither CD4 nor
CXCR4was altered from controls inmultiple cell lines expressing
shRNAs targeting GOLGI49 (Figure S7B). In keeping with a pre-
vious report, confocal imaging showed colocalization between
stably expressed GOLGI49 containing a FLAG epitope tag and
the known Golgi protein, TGN46 (Figure 6K) (Takatalo et al.,
2008). Using MORR, we identified a Golgi-resident HDF,
GOLGI49, whose loss results in an early block in the viral life
cycle, most likely at the level of either viral binding or viral fusion
to the host’s plasma membrane.
The NPC Protein SEC13 Is Necessary for HIV-1
Replication after PIC Nuclear Entry but prior to Viral
Integration
Depletion of SEC13 was found to inhibit HIV-1 infection. A WD-
repeat family protein, SEC13, resides in both the ER, where it is
involved in COPII vesicle formation and trafficking (Hsia et al.,
2007), and the NPC’s cytosolic and nuclear portions.
SEC13’s distinct residences, together with the evolving role
of the NPC in HIV-1 replication, made it an interesting candi-
date for further evaluation. siRNAs against SEC13 each in-
hibited either HIV-1 IIIB or VSV-G-pseudotyped HIV-1 NL4-3-
GFP (Figures 7A and 7B). This effect was lentiviral specific
because SEC13’s loss did not alter infection by VSV-G-pseu-
dotyped MLV-GFP. SEC13 depletion also lowered the expres-
sion of GFP from proviruses containing either an LTR or CMV
promoter, indicating it was not specifically required for LTR ac-
tivity (Figure S7C). We next rescued HIV-1 infection using an
shRNA-resistant SEC13 cDNA (Figures 7C and 7D). SEC13
was also required for HIV-1 replication in primary human
CD4+ T cells (Figures 7E and 7F) with similar results seen
with the Jurkat T cell line (Figures S7D and S7E). While deple-
tion of SEC13 did not alter the levels of either late RT products
or 2-LTR circles, it did reduce HIV-1 integration, suggesting
that it functions in the intranuclear portion of the HIV-1 life cycle
(Figure 7G). In keeping with its reported locations, confocal im-
aging showed that SEC13 localized to both the ER and the nu-
cleus, with the latter population partially colocalizing with other
NPC proteins (Figure 7H).
DISCUSSION
RNAi screens have revealed the dependencies of multiple path-
ogens and in the case of HIV-1 enabled the discovery of
numerous HDFs (Brass et al., 2008; Ko¨nig et al., 2008; Zhou
et al., 2008). However, the overlap of candidates identified
across these efforts has been low (Bushman et al., 2009; Goff,
2008). To address this issue and attempt to saturate the HDF
screen, we set out to generate a high-confidence list of host
proteins required for viral replication. To do this, we used three
large-scale siRNA resources and integrated these primary data
sets with those from earlier studies by adapting an established
program, RIGER. This MORR-RIGER strategy produced a
quantitatively integrated data set that highly ranked both known
HDFs and previously unappreciated ones. A comparison of theell Reports 9, 752–766, October 23, 2014 ª2014 The Authors 761
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Figure 6. Depletion of GOLGI49 Prevents HIV-1 Entry
(A) HeLa cells were transfectedwith the indicated siRNAs. At 72 hr posttransfection, cells were infectedwith HIV-1 IIIB. After 48 hr, cells were stainedwith anti-CA.
The percentage of infected cells was measured and normalized to the control siRNA-treated cells.
(B) siRNA-mediated depletion was evaluated by qPCR measurement of mRNA levels from (A). mRNA levels were normalized to those of the control siRNA-
transfected cells.
(C) TZM-bl HeLa cells stably expressing the indicated short hairpin RNAs (shRNA) against the 30 UTR of the GOLGI49 mRNA (3Ush) or a control shRNA against
firefly luciferase (FLuc) were either mock transfected (mock) or transiently transfected with a vector expressing the GOLGI49 cDNA. After 48 hr, the cells were
infected with HIV-IIIB. After an additional 48 hr, the cells were stained with anti-CA. The percentage of infected cells was measured and normalized to the FLuc
control cells.
(D) GOLGI49 30 UTR shRNA-mediated depletion was confirmed by measuring mRNA from (C). mRNA levels were normalized to those of the FLuc control cells.
3Ush, 30UTR shRNA.
(E) Primary human CD4+ T cells stably expressing either the control FLuc shRNA or one of the indicated shRNAs against GOLGI49 (Sh1-3) were infected with
HIV-1 NL4-3-GFP. The percentage of GFP-positive cells was measured at 48 hr postinfection and normalized to the control cells.
(F) GOLGI49 shRNA-mediated depletion in primary CD4+ T cells in (E) was confirmed by qPCR. mRNA levels were normalized to those of the FLuc control cells.
(G) TZM-bl HeLa cells stably expressing the indicated shRNAswere infectedwith HIV-1 IIIB, LTR-GFP-VSV-G, orMLV-GFP-VSV-G. After 48 hr, the percentage of
infected cells was measured and normalized to the levels found in the FLuc control cells.
(H) TZM-bl HeLa cells stably transduced with viruses containing an empty vector (pQCXIP, Vector), a GOLGI49 cDNA (GOLGI49), or an HA-tagged GOLGI49
cDNA (HA-GOLGI49) were infected with the indicated fluorescence protein reporter viruses. The percentage of infected fluorescent cells was measured at 48 hr
postinfection and normalized to the control cells.
(I) HeLa cells were transfected with the indicated siRNAs. At 72 hr posttransfection, cells were infected with HIV-1 IIIB or HIV-1 NL4-3-GFP (X4). As negative
controls, infections were performed in the presence of either azidothymidine (AZT) (2.5 uM) or using heat-inactivated virus. Cells were harvested at 18 hr
(legend continued on next page)
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RIGER3 and RIGER 5 HDF data sets with a set of expert-
selected HDFs (Reactome) showed that both analyses enriched
for these test genes and that integrating all five screens improved
this metric in several instances.
Identifying OTEs
To further improve the HDF data set, we determined expressed
genes in the cells used for the screens and used this data to re-
move poorly expressed genes, which likely represent OTEs. A
recently created OTE identification program, GESS, was used
to rule out prominent OTEs. Therefore, by using RIGER to inte-
grate all the HDF screens, and combining this with gene expres-
sion filtering, we produced a rigorous genome-wide data set that
quantifies each gene’s role in HIV-1 replication.
Individual Screens Are Dominated by False Negatives
As different experimental approaches may contribute to inter-
screen variability, we kept these factors constant within the
MORR screens. Nonetheless, a comparison of the data between
the MORR screens demonstrates a low level of exact gene over-
lap. Thus, while the field has become accustomed to OTEs,
these data also reveal the false negatives encountered using
these resources, a concern recently hypothesized (Adamson
et al., 2012; Hao et al., 2013). Having a data set with known pos-
itives allowed the direct testing of this possibility. A useful illus-
tration of false negatives is the MED complex, of which only 4
out of 26 total components scored in four or more individual
screens: MED6, 7, 14, and 28 (Table S2). Similar results are
seen when comparing the NPC, THOC, and NF-kB pathway
components across the screen data sets.
RIGER Reduces False Negatives
False negatives arise because of the variability in the pene-
trance of RNAi and the inability to easily take advantage of
hypomorphs. We suggest that the near saturation of several
protein complexes using the MORR-RIGER method may arise
because while each siRNA library is limited by intrinsic false
negatives, the use of a combined approach offsets this limita-
tion by taking advantage of the best that each of the libraries
has to offer. All of the previously published HIV screens provide
lists with strict thresholds for siRNAs that score. However,
siRNA effects are incomplete and produce a range of hypomor-
phic phenotypes that still provide information even if falling
short of the selection cutoffs. Using RIGER to assess all five
data sets minimizes the loss of data regarding potential HDFs
whose phenotypic penetrance did not surpass a strict cutoff.
We propose that a quantitatively integrated analysis of similar
screens using orthologous reagents permits additional informa-postinfection and subjected to DNA extraction. Late RT product was measured
siRNA-treated cells.
(J) HeLa cells were transfected with the indicated siRNAs (siGFP is a negative co
containing a BlaM-Vpr fusion protein pseudotyped with either VSV-G or an HI
substrate and fluorescence was measured. Cells at the lower-right corner of the
population, and numbers in that region represent percent positive cells.
(K) Confocal imaging of HeLa cells stably expressing HA-GOLGI49 (HA, red) and th
on differential interference contrast (DIC) images (far right). Percent colocalizatio
Results throughout are the mean of three independent experiments ± SD. *p%
Ction to be extracted from each separate effort and strengthens
the conclusions of this work. These analyses can also be used
to evaluate the quality of a given screening effort or reagent.
For example, if we know that MED components should be
found in an HDF screen, we can determine how many of the
total expected MED subunits were recovered. To evaluate
this quality metric, we have surveyed each of the five HDF
screens for the percentage of the total MED and NUPs de-
tected. This analysis revealed that, overall, increasing the num-
ber of independent screens in a combined analysis improves
the detection of relevant genes (KS method). These results
also further clarify the origins of the lack of overlap seen among
the earlier screens and empirically indicate that false negatives
and hypomorphs play a significant role in screen-to-screen
discordance.
HDFs
While the MORR screens confirmed many known host factors,
they also identified several novel HDFs. Although more remains
to be done to define themechanism underlying thesemany host-
viral interactions, we focused on validating a subset of genes
that function at various stages of the HIV-1 life cycle: entry
(GOLGI49), reverse transcription (ATIC), integration (SEC13),
and transcription (inhibitory, SUPT16H). A growing number of
HDFs play roles in the post-nuclear-entry HIV-1 life cycle (Di
Nunzio, 2013). Depletion of SEC13 inhibited HIV-1 after nuclear
entry but before proviral integration. SEC13 is a nucleoporin
that localizes to both the nuclear and the cytoplasmic faces of
the NPC. Nuclear SEC13 associates with chromatin and may
be an activator of early transcription (Capelson et al., 2010).
Together with its requirement for HIV integration, these data sug-
gest that SEC13 may play a role in helping the HIV-1 PIC interact
effectively with the host’s chromatin.
In carrying out this study, our goal was to improve our under-
standing of HIV-1’s dependencies by (1) minimizing false nega-
tives by taking advantage of the best that each siRNA library
offers, (2) using gene expression filtering to decrease OTEs,
and (3) avoiding the pitfalls of hypomorphism and absolute cut-
offs in candidate selection by integrating multiple screens
(RIGER; Figure 3C). By integrating all of the data generated
with the orthologous libraries, RIGER in effect performs a
large-scale reagent redundancy-based evaluation of the entire
genome’s role in HIV replication. However, since RIGER may
bias against specific HDFs that possess wide phenotypic varia-
tion between screens, we favor using both RIGER and a
traditional reagent redundancy-based validation method. This
strategy may prove useful to integrate data sets from multiple
screens for other phenotypes performed by separate groupsby qPCR using described primer and probe set and normalized to the control
ntrol siRNA targeting GFP). Cells were infected 72 hr later with an HIV-1 virus
V-1 ENV (HX2, X4-tropic). Infected cells were incubated with the CCF2-AM
diagonal distribution of the no-infection control (No) were gated as a positive
e endogenous Golgi protein TGN46 (green). Cell outlines were rendered based
n ± SD is provided in the bottom merged panel.
0.05 (Student’s t test).
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Figure 7. SEC13 Is Needed for HIV-1 Replication after Nuclear Entry but prior to Integration
(A) MAGI HeLa cells were transfected with the indicated siRNAs and infected 72 hr later with the noted viruses. The percentage of infected cells was measured at
48 hr postinfection and normalized to the control siRNA-treated cells.
(B) siRNA-mediated depletion was tested by measuring SEC13 mRNA from the cells in (A). mRNA levels are normalized to those of the negative control cells.
(C) TZM-bl HeLa cells stably expressing an shRNA against the coding sequence of the SEC13 mRNA (CDsh), the 30 UTR of the SEC13 mRNA (3Ush), or a
scrambled control shRNA (Scram) were transfected with either an empty expression vector (vector) or a vector expressing the SEC13 cDNA. After 48 hr, the cells
were infected with HIV-IIIB. After an additional 48 hr, the cells were stained with anti-CA. The percentage of infected cells was measured and normalized to the
control siRNA-transfected cells. The exogenously expressed SEC13 cDNA rescued HIV replication in the 3Ush cells, but not the CDsh cells.
(D) SEC13 shRNA targeting efficacy was confirmed by measuring mRNA from cells in (C). Values were normalized to the mRNA level of the scramble shRNA
control cells.
(E) Primary CD4+ T cells stably expressing either FLuc shRNA or two different SEC13 shRNAs were infected with NL4-3-GFP-VSV-G. The percentage of infected
cells was measured 48 hr later and normalized to the values determined for the FLuc shRNA-transduced cells.
(F) SEC13 shRNA-mediated depletion efficacy in cells in (E) was determined. mRNA levels were normalized to those of FLuc shRNA-transduced cells.
(legend continued on next page)
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that are currently hampered by OTEs, hypomorphs, and false
negatives. Additional screening methods, i.e., haploid cells and
CRISPR, can also be integrated together with siRNA efforts
using RIGER.Wewill continue to improve these efforts by adding
such capabilities as well as those integrating bioinformatic data
sets to generate rankings based on screening results together
with functional and physical gene associations.
EXPERIMENTAL PROCEDURES
Cell Lines
Cells were from the NIHAIDSReagent Repository: HeLaMAGI, HeLa T4, TZM-
bl, HeLa-Tat-III/CMV/d1EGFP (#11062), HeLa-Tat-III/LTR/d1EGFP (#11063,
both fromParent et al., 2005), and Jurkat Clone E6-1 (# 177;Weiss et al., 1984).
Viruses
TheHIV-1 IIIB strain and the NL4-3 plasmidwere from the NIH AIDS repository.
VSV-G pseudotyped viruses were created by cotransfecting pCG-VSV-G and
pCG-Gag-Pol vectors using the viral constructs (HIV-YFP, HIV-1 LTR-GFP
[LTR-GFP], CMV-ZSG [pPHAGE-CMV-ZSG], and MLV-GFP).
Antibodies
For the MORR screens, we used the primary antibody, anti-HIV-1 p24 mouse
monoclonal antibody mab-183 (NIH AIDS Reagent Repository), and the sec-
ondary antibody, goat anti-mouse Alex Flour 488 (Invitrogen), for immunofluo-
rescence detection of HIV-1 infection following a published protocol.
SUPT16H (sc-165987), GAPDH (sc-25778), and actin (sc-7210) antibodies
from Santa Cruz, and a mouse ATIC antibody (A8480) from Sigma, were
used for immunoblots. Flow cytometry used CD4-FITC (Immunotech PN
IM0448) and CXCR4-PE (BD Pharmigen 555974).
Plasmids
pQCXIP-HA-GOLGI49 and pQCXIP-GOLGI49 were constructed by subclon-
ing GOLGI49/C3orf58 with or without an N-terminal hemagglutinin (HA) tag
into the pQCXIP retroviral vector (Clontech) using AgeI and BamHI sites.
pQCXIP-FLAG-SEC13 was constructed by subcloning SEC13 with N-terminal
FLAG tag into the pQCXIP vector using NotI and BamHI sites. Pseudotyped
viruses were packaged using pCG-VSV-G and pCG-Gag-Pol vectors.
pDEST40-GOLGI49 and pDEST40-SEC13 were constructed through
Gateway LR reactions of pDONR223-GOLGI49 or pDONR223-SEC13 (Open
Biosystems) with a pcDNA-DESR40 vector (Invitrogen) using LR Clonase
enzyme mix (Invitrogen).
siRNA Screening
The RNAi screens were done in triplicate using three siRNA libraries: Silencer
Select, Ambion (21,584 siRNA pools, three oligos per pool); esiRNA, Sigma
(15,300 siRNA pools, complex pools); and Dharmacon RefSeq27 Reversion
Pools (4,506 siRNA pools, four oligos per pool) following a previous estab-
lished protocol (Brass et al., 2008; Zhu et al., 2012). Briefly, HeLa MAGI cells
(approximately 600 per well) were reverse transfectedwith 50 nM final concen-
tration siRNA using Oligofectamine (Invitrogen) in 384-well plates. The cells
were infected 72 hr later with HIV-IIIB in 30 ml fresh Dulbecco’s modified
Eagle’s medium. Cells were fixed 48 hr later (4% paraformaldehyde; Sigma)
in Dulbecco’s phosphate-buffered saline (D-PBS) (Sigma), permeabilized
(0.2% Triton X-100 in D-PBS), and stained for intracellular HIV-1 p24 expres-
sion using the anti-p24 antibodymAB-183 (NIH AIDS Reagent Repository) and(G) HeLa-T4 cells were transfected with the indicated siRNAs for 72 hr. Cells were
with AZT. DNA was harvested and subjected to qPCR assaysmeasuring late RT (b
The relative level of viral DNAs was normalized to cells transfected with the cont
(H) Confocal imaging of HeLa cells stably expressing SEC13-FLAG (green) or th
recognizes the NPC protein, NUP153 (red), or one that recognizes the NPC com
either NUP153 or mAB414 with SEC13 ± SD from multiple cells from multiple fie
Results throughout are the mean of three independent experiments ± SD. *p%
Cgoat anti-mouse Alexa 488. Cellular DNA was stained using Hoechst 33342
(Invitrogen). Immunostained cells were imaged using an Image Xpress Micro
microscope (Molecular Devices) and the images analyzed to determine
percent infection and cell number (cell scoring module; Metamorph, Molecular
Devices). The Qiagen (Ko¨nig et al., 2008) primary screen data set was kindly
provided by S. Chanda (Burnham Institute). The Rosetta (Zhou et al., 2008) pri-
mary screen data set was kindly provided by A. Espeseth (Merck & Co.).
Luciferase Assay
293T cells were transfectedwith the indicated firefly luciferase reporters, along
with pRL-TK (Promega) as a control. The cells were processed using the Dual-
Glo Luciferase Assay System (Promega), and the plates were read using a
Luminoskan Luminometer (Thermo Fisher Scientific). The HIV-1 LTR luciferase
reporter construct was obtained through the AIDS Research and Reference
Reagent Program. The TAR-deleted (dTAR) LTR luciferase reporter construct
was a kind gift fromDr. AndrewBadley (Mayo Clinic). The HIV-1 Tat expression
plasmid was a kind gift from Dr. Richard Mulligan (Harvard Medical School).
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